killer T cells tagged posts

Research demonstrates that Killer T cells can support Tissue Regeneration

Killer T cells support tissue regeneration
Wound healing and target killing are both effector mechanisms of CD8 T cells. (A) Combined proliferation and killing assay in the presence of influenza-specific CD8 T cells and varying amounts of pulsed peptides on MRC-5 and HaCaT cells seeded in a 30:70 ratio. Left, representative image with labels (0 versus 5 h; T cells only versus T cells + 100 ng/ml peptide). Right, representative quantification of Cas3/7 activity (green) and HaCaT proliferation (red) with titrated amounts of influenza peptide, with statistical verification across experiments using normalized area under the curve (AUC, n = 3, one-way ANOVA, symbols indicate individual experiments). Scale bars = 400 µm; enhanced for improved visibility...
Read More

‘Bad Fat’ Suppresses Killer T cells from Attacking Cancer

In order for cancer to grow and spread, it has to evade detection by our immune cells, particularly specialized “killer” T cells. Salk researchers led by Professor Susan Kaech have found that the environment inside tumors (the tumor microenvironment) contains an abundance of oxidized fat molecules, which, when ingested by the killer T cells, suppresses their ability to kill cancer cells. In a vicious cycle, those T cells, in need of energy, increase the level of a cellular fat transporter, CD36, that unfortunately saturates them with even more oxidized fat and further curtails their anti-tumor functions.

The discovery, published online in Immunity on June 7, 2021, suggests new pathways for safeguarding the immune system’s ability to fight cancer by reducing the oxidative lipid dama...

Read More

In fight against COVID Variants some firms Target Tcell Jabs

covid-19
Credit: Unsplash/CC0 Public Domain

Getting COVID vaccines into the arms of the world’s population is an international priority—but will today’s jabs stay effective against virus variants that are spreading across the globe?

It is one of the big questions about the pandemic, with Pfizer chief Albert Bourla recently acknowledging that it is likely a booster will be needed to help extend the protection conferred by its vaccine and ward off new variants.

A recent study presented a mixed picture. It found that the antibody response of current vaccines could fail against variants. However, a second immune response in the form of killer T cells—which attack already infected cells and not the virus itself—remained largely intact.

Several startups are working on developing shots ...

Read More